Swiss National Bank’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $999K | Hold |
139,100
| – | – | ﹤0.01% | 2139 |
|
|
2025
Q1 | $833K | Buy |
139,100
+20,700
| +17% | +$124K | ﹤0.01% | 2206 |
|
|
2024
Q4 | $924K | Sell |
118,400
-3,000
| -2% | -$23.4K | ﹤0.01% | 2236 |
|
|
2024
Q3 | $1.31M | Sell |
121,400
-2,600
| -2% | -$28.1K | ﹤0.01% | 2092 |
|
|
2024
Q2 | $1.05M | Hold |
124,000
| – | – | ﹤0.01% | 2153 |
|
|
2024
Q1 | $833K | Buy |
124,000
+31,400
| +34% | +$211K | ﹤0.01% | 2308 |
|
|
2023
Q4 | $544K | Sell |
92,600
-25,600
| -22% | -$151K | ﹤0.01% | 2457 |
|
|
2023
Q3 | $1.15M | Hold |
118,200
| – | – | ﹤0.01% | 2163 |
|
|
2023
Q2 | $1.4M | Buy |
118,200
+42,800
| +57% | +$507K | ﹤0.01% | 2119 |
|
|
2023
Q1 | $814K | Sell |
75,400
-4,000
| -5% | -$43.2K | ﹤0.01% | 2365 |
|
|
2022
Q4 | $918K | Buy |
+79,400
| New | +$918K | ﹤0.01% | 2390 |
|